BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Hypothalamus
,
Nosology
,
Quercetin
,
rs2300478
,
IGF1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
glioblastoma cells
Summary
General Info
Curated Studies
Most Correlated Studies
GSK cancer cell line transcript profiling
Glioblastoma cell lines overexpressing HSS1
TP53 knockdown in U251 glioblastoma cells
Glioblastoma cells overexpressing microRNA miR-137
U251 glioblastoma cells with cyclophilin B knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth.
The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells.
Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide.
Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Utility of Primary Glioblastoma Cell Lines
CARv3-TEAM-E T Cells in Glioblastoma
Spectral Analysis Probe to Identify Glioblastoma Cells
Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard T…
Function and Composition of Regulatory B Cells in Participants With Glioblastoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ